GB9922700D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
GB9922700D0
GB9922700D0 GBGB9922700.1A GB9922700A GB9922700D0 GB 9922700 D0 GB9922700 D0 GB 9922700D0 GB 9922700 A GB9922700 A GB 9922700A GB 9922700 D0 GB9922700 D0 GB 9922700D0
Authority
GB
United Kingdom
Prior art keywords
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9922700.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9922700.1A priority Critical patent/GB9922700D0/en
Publication of GB9922700D0 publication Critical patent/GB9922700D0/en
Priority to ARP000104978A priority patent/AR025750A1/en
Priority to DE60036952T priority patent/DE60036952T2/en
Priority to EP07119192A priority patent/EP1878424A3/en
Priority to AU75226/00A priority patent/AU766635B2/en
Priority to MYPI20004435 priority patent/MY126588A/en
Priority to AT00967781T priority patent/ATE376825T1/en
Priority to PL00355232A priority patent/PL355232A1/en
Priority to CN00816263A priority patent/CN1399539A/en
Priority to MXPA02003068A priority patent/MXPA02003068A/en
Priority to NZ517903A priority patent/NZ517903A/en
Priority to KR1020027003833A priority patent/KR20020038771A/en
Priority to CZ20021045A priority patent/CZ20021045A3/en
Priority to TR2002/00777T priority patent/TR200200777T2/en
Priority to EP00964232A priority patent/EP1214053A1/en
Priority to PCT/EP2000/009368 priority patent/WO2001021152A1/en
Priority to IL14867100A priority patent/IL148671A0/en
Priority to ES00967781T priority patent/ES2293923T3/en
Priority to BR0014285-9A priority patent/BR0014285A/en
Priority to CO00072097A priority patent/CO5280082A1/en
Priority to HU0203817A priority patent/HUP0203817A3/en
Priority to KR1020027003856A priority patent/KR20020048942A/en
Priority to PCT/EP2000/009367 priority patent/WO2001021151A1/en
Priority to JP2001524578A priority patent/JP2003509452A/en
Priority to CA002383110A priority patent/CA2383110A1/en
Priority to TR2002/00776T priority patent/TR200200776T2/en
Priority to AU77825/00A priority patent/AU764368B2/en
Priority to IL14867300A priority patent/IL148673A0/en
Priority to PL00355287A priority patent/PL355287A1/en
Priority to BR0014281-6A priority patent/BR0014281A/en
Priority to EP00967781A priority patent/EP1214054B1/en
Priority to NZ517901A priority patent/NZ517901A/en
Priority to CN00815945A priority patent/CN1391463A/en
Priority to CA2383105A priority patent/CA2383105C/en
Priority to CZ20021044A priority patent/CZ20021044A3/en
Priority to MXPA02003069A priority patent/MXPA02003069A/en
Priority to CO00072101A priority patent/CO5200838A1/en
Priority to ARP000104977A priority patent/AR025749A1/en
Priority to HU0202846A priority patent/HUP0202846A3/en
Priority to JP2001524577A priority patent/JP4763197B2/en
Priority to ARP000104979A priority patent/AR032597A1/en
Priority to ZA200202269A priority patent/ZA200202269B/en
Priority to ZA200202268A priority patent/ZA200202268B/en
Priority to NO20021431A priority patent/NO20021431L/en
Priority to NO20021432A priority patent/NO20021432L/en
Priority to HK02108461.1A priority patent/HK1046861A1/en
Priority to US11/119,994 priority patent/US20050201946A1/en
Priority to US12/388,156 priority patent/US20090155309A1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB9922700.1A 1999-09-24 1999-09-24 Vaccine Ceased GB9922700D0 (en)

Priority Applications (48)

Application Number Priority Date Filing Date Title
GBGB9922700.1A GB9922700D0 (en) 1999-09-24 1999-09-24 Vaccine
ARP000104978A AR025750A1 (en) 1999-09-24 2000-09-22 VACCINES
DE60036952T DE60036952T2 (en) 1999-09-24 2000-09-22 INFLUENZA VIRUS VACCINE COMPOSITION FOR NASAL APPLICATION
EP07119192A EP1878424A3 (en) 1999-09-24 2000-09-22 Novel vaccine
AU75226/00A AU766635B2 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
MYPI20004435 MY126588A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
AT00967781T ATE376825T1 (en) 1999-09-24 2000-09-22 INFLUENZA VIRUS VACCINE COMPOSITION FOR NASAL USE
PL00355232A PL355232A1 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
CN00816263A CN1399539A (en) 1999-09-24 2000-09-22 Adjuvant comprising polyxyethylene alkyl ether or ester and at least one nonionic surfactant
MXPA02003068A MXPA02003068A (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant.
NZ517903A NZ517903A (en) 1999-09-24 2000-09-22 One dose intranasal influenza virus vaccine with split influenza viral antigens
KR1020027003833A KR20020038771A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
CZ20021045A CZ20021045A3 (en) 1999-09-24 2000-09-22 Auxiliary preparation
TR2002/00777T TR200200777T2 (en) 1999-09-24 2000-09-22 At least one non-ionic surfactant adjuvant with polyoxyethylene alkyl ether or ester.
EP00964232A EP1214053A1 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant
PCT/EP2000/009368 WO2001021152A1 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
IL14867100A IL148671A0 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
ES00967781T ES2293923T3 (en) 1999-09-24 2000-09-22 INTRANASAL VACCINE AGAINST THE INFLUENZA VIRUS.
BR0014285-9A BR0014285A (en) 1999-09-24 2000-09-22 Adjuvants comprising a polyoxyethylene alkyl ester or ether and at least one nonionic surfactant
CO00072097A CO5280082A1 (en) 1999-09-24 2000-09-22 NEW VACCINE
HU0203817A HUP0203817A3 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
KR1020027003856A KR20020048942A (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant
PCT/EP2000/009367 WO2001021151A1 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
JP2001524578A JP2003509452A (en) 1999-09-24 2000-09-22 Adjuvant containing polyoxyethylene alkyl ether or ester and at least one nonionic surfactant
CA002383110A CA2383110A1 (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one non-ionic surfactant
TR2002/00776T TR200200776T2 (en) 1999-09-24 2000-09-22 Intranasal flu virus vaccine.
AU77825/00A AU764368B2 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
IL14867300A IL148673A0 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
PL00355287A PL355287A1 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
BR0014281-6A BR0014281A (en) 1999-09-24 2000-09-22 Vaccine against intranasal flu virus
EP00967781A EP1214054B1 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
NZ517901A NZ517901A (en) 1999-09-24 2000-09-22 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one non-ionic surfactant
CN00815945A CN1391463A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
CA2383105A CA2383105C (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
CZ20021044A CZ20021044A3 (en) 1999-09-24 2000-09-22 Use of influenza virus antigen for preparing a vaccine
MXPA02003069A MXPA02003069A (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine.
CO00072101A CO5200838A1 (en) 1999-09-24 2000-09-22 VACCINES
ARP000104977A AR025749A1 (en) 1999-09-24 2000-09-22 VACCINES
HU0202846A HUP0202846A3 (en) 1999-09-24 2000-09-22 Intranasal influenza virus vaccine
JP2001524577A JP4763197B2 (en) 1999-09-24 2000-09-22 New vaccine
ARP000104979A AR032597A1 (en) 1999-09-24 2000-09-22 USE OF ANTIGENS OF THE VIRUS OF THE INACTIVATED FLU, IN THE PREPARATION OF VACCINES OF A SINGLE INTRANASAL DOSE; METHOD FOR THE PROPHYLAXIS OF DISEASES OR OF INFLUENCES IN PATIENTS; EQUIPMENT THAT INCLUDES SUCH VACCINES IN SINGLE DOSE AND METHOD FOR MANUFACTURING VACCINES FOR THE FLU FOR APLI
ZA200202269A ZA200202269B (en) 1999-09-24 2002-03-20 Intranasal influenza virus vaccine.
ZA200202268A ZA200202268B (en) 1999-09-24 2002-03-20 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one non-ionic surfactant.
NO20021431A NO20021431L (en) 1999-09-24 2002-03-21 Intranasal influenza virus vaccine
NO20021432A NO20021432L (en) 1999-09-24 2002-03-21 Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
HK02108461.1A HK1046861A1 (en) 1999-09-24 2002-11-21 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant
US11/119,994 US20050201946A1 (en) 1999-09-24 2005-05-02 Intranasal influenza virus vaccine
US12/388,156 US20090155309A1 (en) 1999-09-24 2009-02-18 Novel vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922700.1A GB9922700D0 (en) 1999-09-24 1999-09-24 Vaccine

Publications (1)

Publication Number Publication Date
GB9922700D0 true GB9922700D0 (en) 1999-11-24

Family

ID=10861592

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9922700.1A Ceased GB9922700D0 (en) 1999-09-24 1999-09-24 Vaccine

Country Status (2)

Country Link
GB (1) GB9922700D0 (en)
ZA (2) ZA200202268B (en)

Also Published As

Publication number Publication date
ZA200202268B (en) 2003-02-03
ZA200202269B (en) 2003-11-17

Similar Documents

Publication Publication Date Title
IL145043A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
HUP0202885A3 (en) Vaccines
HK1105581A1 (en) Vaccine composition
EP1083926A4 (en) Vaccine
GB9910812D0 (en) Vaccine composition
GB9915204D0 (en) Vaccine
GB9901254D0 (en) Vaccines
GB0027072D0 (en) Vaccine
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
MXPA01010701A (en) Vaccine.
GB9930591D0 (en) Component for vaccine
GB9909072D0 (en) Vaccine
GB9930585D0 (en) Component for vaccine
GB9904405D0 (en) Vaccine
GB9925619D0 (en) Vaccine
GB9922700D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9916677D0 (en) Vaccine
GB9922703D0 (en) Vaccine
GB9917144D0 (en) Vaccine
GB9927336D0 (en) Vaccine
GB9925618D0 (en) Vaccine
GB9905511D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)